Related Experiment Videos
Hypothyroidism and arthritis during interferon therapy
L D'Hondt1, A Delannoy, C Docquier
1Service de Médecine Interne, Hôpital de Jolimont, Saint-Paul, Belgium.
Clinical Rheumatology
|September 1, 1993
Summary
Autoantibodies are common during interferon therapy, but autoimmune disease symptoms are rare. This case study details a patient who developed arthritis and autoimmune thyroiditis during interferon treatment for chronic myelocytic leukemia.
Area of Science:
- Immunology
- Oncology
- Rheumatology
Background:
- Interferon therapy is frequently associated with autoantibody development.
- Clinical manifestations of autoimmune disease are uncommon despite frequent autoantibody production.
Observation:
- A female patient with chronic myelocytic leukemia (CML) was treated with alpha 2b interferon (IFN).
- During treatment, she developed arthritis and autoimmune thyroiditis with a strongly positive antinuclear factor (ANA).
Findings:
- The patient's arthritis resolved rapidly after discontinuing IFN.
- Nonsteroidal anti-inflammatory drugs (NSAIDs) were initiated alongside IFN discontinuation.
Implications:
- This case highlights a rare but treatable adverse effect of interferon therapy.
- Early recognition and management can alleviate IFN-induced autoimmune complications.